Medtronic is investing €13 million in a high-tech 20,000 square foot facility in Galway, Ireland that will be the manufacturing site for the company’s drug-coated balloon. About 8000 square feet of space will be dedicated to the manufacturing of the IN.PACT Admiral device, which is used for the treatment of peripheral artery disease.
Ireland Remains Competitive in Medical Device Sector“Our global market leadership in DCB [drug-coated balloons] is driving the need to open the new facility here in Galway to provide more patients access to this highly efficacious and safe treatment option for peripheral arterial disease,” said Tony Semedo, senior vice president and president of the Aortic & Peripheral Vascular business at Medtronic in a company release. “Our Galway operations and staff have very specific expertise in this area, which is the platform for this announcement. Once fully operational, this facility will be the only DCB manufacturing area of its kind in Medtronic worldwide.”
The company selected Galway due to its on-site expertise in combination products for its coronary business. The facility will be home to about 100 employees who have backgrounds in quality and manufacturing engineering, and supply chain and production management.